These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
942 related items for PubMed ID: 28806470
1. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Hristovska AM, Duch P, Allingstrup M, Afshari A. Cochrane Database Syst Rev; 2017 Aug 14; 8(8):CD012763. PubMed ID: 28806470 [Abstract] [Full Text] [Related]
2. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Abrishami A, Ho J, Wong J, Yin L, Chung F. Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007362. PubMed ID: 19821409 [Abstract] [Full Text] [Related]
3. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials. Carron M, Zarantonello F, Tellaroli P, Ori C. J Clin Anesth; 2016 Dec 07; 35():1-12. PubMed ID: 27871504 [Abstract] [Full Text] [Related]
4. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Abrishami A, Ho J, Wong J, Yin L, Chung F. Anesth Analg; 2010 Apr 01; 110(4):1239. PubMed ID: 20357160 [Abstract] [Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557 [Abstract] [Full Text] [Related]
6. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment. Chambers D, Paulden M, Paton F, Heirs M, Duffy S, Craig D, Hunter J, Wilson J, Sculpher M, Woolacott N. Health Technol Assess; 2010 Jul 01; 14(39):1-211. PubMed ID: 20688009 [Abstract] [Full Text] [Related]
7. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. Flockton EA, Mastronardi P, Hunter JM, Gomar C, Mirakhur RK, Aguilera L, Giunta FG, Meistelman C, Prins ME. Br J Anaesth; 2008 May 01; 100(5):622-30. PubMed ID: 18385265 [Abstract] [Full Text] [Related]
8. The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis. Hristovska AM, Duch P, Allingstrup M, Afshari A. Anaesthesia; 2018 May 01; 73(5):631-641. PubMed ID: 29280475 [Abstract] [Full Text] [Related]
10. Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects. Wu X, Oerding H, Liu J, Vanacker B, Yao S, Dahl V, Xiong L, Claudius C, Yue Y, Huang Y, Abels E, Rietbergen H, Woo T. BMC Anesthesiol; 2014 May 01; 14():53. PubMed ID: 25187755 [Abstract] [Full Text] [Related]
11. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial. Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA. Anesth Analg; 2010 Jan 01; 110(1):64-73. PubMed ID: 19713265 [Abstract] [Full Text] [Related]
14. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Sacan O, White PF, Tufanogullari B, Klein K. Anesth Analg; 2007 Mar 01; 104(3):569-74. PubMed ID: 17312210 [Abstract] [Full Text] [Related]
15. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery. Geldner G, Niskanen M, Laurila P, Mizikov V, Hübler M, Beck G, Rietbergen H, Nicolayenko E. Anaesthesia; 2012 Sep 01; 67(9):991-8. PubMed ID: 22698066 [Abstract] [Full Text] [Related]
16. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, Nakatsuka I, Takeda J. Anesth Analg; 2013 Aug 01; 117(2):345-51. PubMed ID: 23757472 [Abstract] [Full Text] [Related]
17. Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Patients With Severe Renal Impairment: A Randomized, Double-Blinded Study. Oh MW, Mohapatra SG, Pak T, Hermawan A, Chen CA, Thota B, Chen J, Siu E, Park J, Moon TS. Anesth Analg; 2024 May 01; 138(5):1043-1051. PubMed ID: 38190344 [Abstract] [Full Text] [Related]
18. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†, Kaufhold N, Schaller SJ, Stäuble CG, Baumüller E, Ulm K, Blobner M, Fink H. Br J Anaesth; 2016 Feb 01; 116(2):233-40. PubMed ID: 26787792 [Abstract] [Full Text] [Related]
19. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M, Demeyer I. Anesthesiology; 2007 Feb 01; 106(2):283-8. PubMed ID: 17264722 [Abstract] [Full Text] [Related]
20. Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: a large observational study. Della Rocca G, Pompei L, Pagan DE Paganis C, Tesoro S, Mendola C, Boninsegni P, Tempia A, Manstretta S, Zamidei L, Gratarola A, Murabito P, Fuggiano L, DI Marco P. Acta Anaesthesiol Scand; 2013 Oct 01; 57(9):1138-45. PubMed ID: 23849107 [Abstract] [Full Text] [Related] Page: [Next] [New Search]